Breaking News, Promotions & Moves

Arcutis Names New Chief Financial Officer

Latha Vairavan to succeed David Topper in May 2025.

Author Image

By: Charlie Sternberg

Associate Editor

Latha Vairavan.

Arcutis Biotherapeutics Inc., a commercial-stage biopharmaceutical company, has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the Company. Latha Vairavan, currently vice president and controller, will assume the role of CFO and join the executive team as part of a planned succession. Topper will continue to serve as CFO until the filing of the Company’s first quarter 10-Q and will provide transition support through his departure on May 15, 2025. “On beha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters